Medicure (MCUJF) Amortizatization of Intangibles (2009 - 2026)
Medicure's (MCUJF) quarterly Amortizatization of Intangibles came in at $394500.3 in Q1 2026, up 6.2% year-on-year from $371456.5 in Q1 2025, and down 1.41% quarter-over-quarter from $400134.1 in Q4 2025.
Medicure (MCUJF) Amortizatization of Intangibles (2009 - 2026) Analysis & Trends
Medicure's Amortizatization of Intangibles history runs 18 years deep, the most recent figure standing at $394500.3 for Q1 2026.
- On a quarterly basis, Amortizatization of Intangibles rose 6.2% year-over-year to $394500.3 in Q1 2026; TTM through Mar 2026 was $1.6 million, a 10.51% increase from a year earlier, with the FY2025 full-year figure at $1.5 million, up 12.41% from the prior year.
- Amortizatization of Intangibles eased to $394500.3 in Q1 2026 per MCUJF's latest filing, from $400134.1 in the prior quarter.
- Across five years, Amortizatization of Intangibles topped out at $897859.9 in Q3 2022 and bottomed at $290526.9 in Q1 2022.
- The 5-year median for Amortizatization of Intangibles is $354373.7 (2024), against an average of $398583.3.
- Across the five-year window, Amortizatization of Intangibles plunged 64.11% in 2023 and climbed 16.11% in 2025, its largest moves.
- Year by year, Amortizatization of Intangibles stood at $897859.9 in 2022, then sank by 64.17% to $321726.6 in 2023, then advanced by 15.26% to $370809.9 in 2024, then climbed by 7.91% to $400134.1 in 2025, then declined by 1.41% to $394500.3 in 2026.
- Per Business Quant, the three latest MCUJF Amortizatization of Intangibles figures stand at $394500.3 (Q1 2026), $400134.1 (Q4 2025), and $392382.9 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn | - |
| 3 | Zoetis | 32.42 Bn | 30.48 Bn | 1.62 Bn | - |
| 4 | Takeda Pharmaceutical | 27.48 Bn | 23.42 Bn | 4.39 Bn | - |
| 5 | United Therapeutics | 22.89 Bn | 20.73 Bn | 648.10 Mn | - |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - | - |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn | - |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.44 Bn | 800.70 Mn | 1.30 Mn |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn | - |
| 10 | Medicure | 8.77 Mn | 7.64 Mn | 2.57 Mn | 394,500.28 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 394,500.28 |
| Mar 31, 2026 | 394,500.28 |
| Dec 31, 2025 | 400,134.15 |
| Dec 31, 2025 | 400,134.15 |
| Sep 30, 2025 | 392,382.90 |
| Sep 30, 2025 | 392,382.90 |
| Jun 30, 2025 | 376,012.21 |
| Jun 30, 2025 | 376,012.21 |
| Mar 31, 2025 | 371,456.48 |
| Mar 31, 2025 | 371,456.48 |
| Dec 31, 2024 | 370,809.85 |
| Dec 31, 2024 | 370,809.85 |
| Sep 30, 2024 | 337,937.62 |
| Sep 30, 2024 | 337,937.62 |
| Jun 30, 2024 | 334,131.23 |
| Jun 30, 2024 | 334,131.23 |
| Mar 31, 2024 | 326,529.81 |
| Mar 31, 2024 | 326,529.81 |
| Dec 31, 2023 | 321,726.56 |
| Dec 31, 2023 | 321,726.56 |